Portfolio 2 Investments
Exciva GmbH
biotechnology, pharmaceuticals, life sciences, healthcare
series-b
€51 M
Jan 2026
Investor
Kupando
medtech, biotechnology, oncology, infectious diseases
series-a
€10 M
Mar 2026
Investor